Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-25 @ 5:59 AM
Study NCT ID:
NCT02588456
Status:
TERMINATED
Last Update Posted:
2023-06-22
First Post:
2015-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia
Sponsor:
University of Pennsylvania
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-10
Start Date Type:
None
Primary Completion Date:
2017-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-26
First Submit QC Date:
None
Study First Post Date:
2015-10-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-20
Last Update Post Date:
2023-06-22
Last Update Post Date Type:
ACTUAL